Laskowska M, Leszczyńska-Gorzelak B, Oleszczuk J
Katedry i Kliniki Połoznictwa i Perinatologii Akademii Medycznej w Lublinie.
Ginekol Pol. 2001 Dec;72(12):1198-204.
Preeclampsia is a major complication during human pregnancy. It results from a breakdown in the balance between the vasoconstrictor and vasodilator substances. Angiotensin II is a potent vasoconstrictor, which participates in the regulation of blood pressure and may be involved in the control of vascular tone.
The purpose of this study was to determine the platelet angiotensin II receptor number and angiotensin II level in pregnancies complicated by preeclampsia. Preeclampsia was defined according to American College of Obstetricians and Gynecologists (ACOG) classification.
Ligand binding techniques were used for the examination of platelet angiotensin II binding sites in the third trimester pregnant women. The study was carried out in 13 patients with singleton pregnancy complicated by preeclampsia. A control group consisted of 17 healthy normotensive patients with singleton uncomplicated pregnancy and normal laboratory tests. All studied patients were nonsmokers.
There were no statistically significant differences in patient profiles between groups including gravidity, parity, maternal age, gestational age and height. Maternal weight, BMI and systolic, diastolic blood pressure and mean arterial blood pressure (MAP) were higher in the study group in comparison with the control group. Our study revealed elevated platelet angiotensin II receptor number and decreased maternal angiotensin II level in singleton pregnancies complicated by preeclampsia. There were no correlations between platelet angiotensin II receptor number and plasma angiotensin II level in the studied subjects. Our results are in accord with other published data and point out to the significant role of renin-angiotensin-aldosterone system and angiotensin II receptors in the pathogenesis of preeclampsia.
子痫前期是人类孕期的一种主要并发症。它是由血管收缩物质和血管舒张物质之间的平衡失调所致。血管紧张素II是一种强效血管收缩剂,参与血压调节,可能还涉及血管张力的控制。
本研究旨在确定子痫前期合并妊娠患者的血小板血管紧张素II受体数量及血管紧张素II水平。子痫前期根据美国妇产科医师学会(ACOG)的分类来定义。
采用配体结合技术检测孕晚期孕妇血小板血管紧张素II结合位点。该研究纳入了13名单胎妊娠合并子痫前期的患者。对照组由17名健康的血压正常的单胎妊娠且实验室检查正常的患者组成。所有研究对象均不吸烟。
两组在妊娠次数、产次、产妇年龄、孕周和身高方面的患者特征无统计学显著差异。与对照组相比,研究组的产妇体重、BMI、收缩压、舒张压及平均动脉压(MAP)更高。我们的研究显示,单胎妊娠合并子痫前期患者的血小板血管紧张素II受体数量升高,而母体血管紧张素II水平降低。在所研究的对象中,血小板血管紧张素II受体数量与血浆血管紧张素II水平之间无相关性。我们的结果与其他已发表的数据一致,并指出肾素-血管紧张素-醛固酮系统及血管紧张素II受体在子痫前期发病机制中的重要作用。